Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.6850
-0.0300 (-4.20%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Adial Pharmaceuticals Stock Forecast
ADIL's stock price has decreased by -59.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Adial Pharmaceuticals stock has a target of 8.00, which predicts an increase of 1,067.88% from the current stock price of 0.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Adial Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,067.88% | Nov 14, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +21,797.81% | Jul 11, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 17, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +43,695.62% | Oct 13, 2021 |
| Litchfield Hills | Litchfield Hills | Strong Buy Initiates $125 | Strong Buy | Initiates | $125 | +18,148.18% | Jun 29, 2021 |
Financial Forecast
Revenue This Year
n/a
from 71.68M
Revenue Next Year
n/a
EPS This Year
-1.78
from -2.72
EPS Next Year
-1.21
from -1.78
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.28 | -1.05 | -0.58 | ||
| Avg | -1.78 | -1.21 | -0.94 | ||
| Low | -2.65 | -1.34 | -1.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.